Wednesday, July 8, 2026

Drug profile · INN

urea c-13

urea c-13 (PYLORI-CHEK BREATH TEST) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 24
News articles 0
Drug details — urea c-13
US status
approved
Class
Route
ORAL
Patents
0
Programs
24
Data quality
0.84

Quick answer

urea c-13 (PYLORI-CHEK BREATH TEST) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN urea c-13
Brand PYLORI-CHEK BREATH TEST
Mechanism Diagnostic agent
Route ORAL
Formulation FOR SOLUTION

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. 18-02/ClotriBet-C Phase 3 · Alphapharm · moderate to severely inflamed candidiasis of the skin
  2. N-Acetylcysteine (NAC) Treatment Phase 3 · First People's Hospital · Thrombotic Microangiopathy
  3. Test - Bimatoprost 0.01% Ophthalmic Solution Phase 3 · Amneal Pharma Europe · Glaucoma, Open-Angle
  4. Test Product Phase 3 · Amneal Pharma Europe · Asthma
  5. N-Acetylcysteine (NAC) Phase 2 · Cumberland Pharmaceuticals · Radiocontrast Nephropathy
  6. N-acetylcysteine (NAC) Phase 2 · BRIGHT MINDS BIOSCIENCES · Nicotine Dependence
  7. Neoadjuvant Chemotherapy (NACT) Phase 2 · First People's Hospital · HR+/HER2- Breast Cancer
  8. Test Drug Phase 2 · BRIGHT MINDS BIOSCIENCES · Heroin Dependence

Frequently asked questions

What is urea c-13?

urea c-13 (PYLORI-CHEK BREATH TEST) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for urea c-13?

PYLORI-CHEK BREATH TEST is a marketed brand name for urea c-13. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of urea c-13?

urea c-13 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.